Skip to main content
Top
Gepubliceerd in:

24-11-2022 | Original Paper

Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial

Auteurs: Jianjun Ou, Robert C. Smith, Russell H. Tobe, Jingjing Lin, Jen Arriaza, Jed W. Fahey, Ruiting Liu, Ying Zeng, Yanan Liu, Lian Huang, Yidong Shen, Yamin Li, Daomeng Cheng, Brian Cornblatt, John M. Davis, Jingping Zhao, Renrong Wu, Hua Jin

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 2/2024

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Sulforaphane has been reported to possibly improve core symptoms associated with autism spectrum disorders from mostly small size studies. Here we present results of a larger randomized clinical trial (N = 108) in China. There were no significant changes in caregiver rated scales between sulforaphane and placebo groups. However, clinician rated scales showed a significant improvement in the sulforaphane group, and one third of participants showed at least a 30% decrease in score by 12 weeks treatment. The effects of sulforaphane were seen across the full range of intelligence and greater in participants over 10 years. Sulforaphane was safe and well-tolerated even for young children. The inconsistent results between caregiver and clinician rated scales suggest more clinical trials are needed to confirm our findings.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
go back to reference Achenbach, T. M., & Rescorla, L. A. (2000). Manual for the ASEBA preschool forms & profiles. VT University of Vermont, Research Center for Children, Youth, & Families. Achenbach, T. M., & Rescorla, L. A. (2000). Manual for the ASEBA preschool forms & profiles. VT University of Vermont, Research Center for Children, Youth, & Families.
go back to reference Achenbach, T. M., & Rescorla, L. A. (2001). Manual for the ASEBA School-Age Forms & Profiles. VT University of Vermont, Research Center for Children, Youth, & Families. Achenbach, T. M., & Rescorla, L. A. (2001). Manual for the ASEBA School-Age Forms & Profiles. VT University of Vermont, Research Center for Children, Youth, & Families.
go back to reference Anagnostou, E., Jones, N., Huerta, M., Halladay, A. K., Wang, P., Scahill, L., Horrigan, J. P., Kasari, C., Lord, C., Choi, D., Sullivan, K., & Dawson, G. (2015). Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder. Autism, 19, 622–636. https://doi.org/10.1177/1362361314542955CrossRefPubMed Anagnostou, E., Jones, N., Huerta, M., Halladay, A. K., Wang, P., Scahill, L., Horrigan, J. P., Kasari, C., Lord, C., Choi, D., Sullivan, K., & Dawson, G. (2015). Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder. Autism, 19, 622–636. https://​doi.​org/​10.​1177/​1362361314542955​CrossRefPubMed
go back to reference Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B: Methodological, 57, 289–300. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B: Methodological, 57, 289–300.
go back to reference Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L., Metzger, L. M., Shoushtari, C. S., Splinter, R., & Reich, W. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders, 33, 427–433. https://doi.org/10.1023/a:1025014929212CrossRefPubMed Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L., Metzger, L. M., Shoushtari, C. S., Splinter, R., & Reich, W. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders, 33, 427–433. https://​doi.​org/​10.​1023/​a:​1025014929212CrossRefPubMed
go back to reference Dunn, L. M., & Dunn, D. M. (2007). Peabody picture vocabulary test (4th ed.). London. Dunn, L. M., & Dunn, D. M. (2007). Peabody picture vocabulary test (4th ed.). London.
go back to reference Fahey, J. W., Wade, K. L., Stephenson, K. K., Panjwani, A. A., Liu, H., Cornblatt, G., Cornblatt, B. S., Ownby, S. L., Fuchs, E., Holtzclaw, W. D., & Cheskin, L. J. (2019). Bioavailability of sulforaphane following ingestion of glucoraphanin-rich broccoli sprout and seed extracts with active myrosinase: A pilot study of the effects of proton pump inhibitor administration. Nutrients, 11, 1489. https://doi.org/10.3390/nu11071489CrossRefPubMedPubMedCentral Fahey, J. W., Wade, K. L., Stephenson, K. K., Panjwani, A. A., Liu, H., Cornblatt, G., Cornblatt, B. S., Ownby, S. L., Fuchs, E., Holtzclaw, W. D., & Cheskin, L. J. (2019). Bioavailability of sulforaphane following ingestion of glucoraphanin-rich broccoli sprout and seed extracts with active myrosinase: A pilot study of the effects of proton pump inhibitor administration. Nutrients, 11, 1489. https://​doi.​org/​10.​3390/​nu11071489CrossRefPubMedPubMedCentral
go back to reference Harrison, P., & Oakland, T. (2008). Adaptive behavior assessment system-II. Western Psychological Services. Harrison, P., & Oakland, T. (2008). Adaptive behavior assessment system-II. Western Psychological Services.
go back to reference Lynch, R., Diggins, E. L., Connors, S. L., Zimmerman, A. W., Singh, K., Liu, H., Talalay, P., & Fahey, J. W. (2017). Sulforaphane from broccoli reduces symptoms of autism: A follow-up case series from a randomized double-blind study. Global Advances in Health & Medicine. https://doi.org/10.1177/2164957X17735826CrossRef Lynch, R., Diggins, E. L., Connors, S. L., Zimmerman, A. W., Singh, K., Liu, H., Talalay, P., & Fahey, J. W. (2017). Sulforaphane from broccoli reduces symptoms of autism: A follow-up case series from a randomized double-blind study. Global Advances in Health & Medicine. https://​doi.​org/​10.​1177/​2164957X17735826​CrossRef
go back to reference Maenner, M., Shaw, K., & Bakian, A. (2021). Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network 11 sites United States, 2018. MMWR Surveillance Summaries, 70(11), 1–6.CrossRefPubMedCentral Maenner, M., Shaw, K., & Bakian, A. (2021). Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network 11 sites United States, 2018. MMWR Surveillance Summaries, 70(11), 1–6.CrossRefPubMedCentral
go back to reference McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., McDougle, C. J., Posey, D., Swiezy, N., Kohn, A., Scahill, L., Martin, A., Koenig, K., Volkmar, F., Carroll, D., Lancor, A., Tierney, E., Ghuman, J., Gonzalez, N. M., Grados, M., Vitiello, B., Ritz, L., Davies, M., Robinson, J., McMahon, D., & Research Units on Pediatric Psychopharmacology Autism Network. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314–321. https://doi.org/10.1056/NEJMoa013171CrossRefPubMed McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., McDougle, C. J., Posey, D., Swiezy, N., Kohn, A., Scahill, L., Martin, A., Koenig, K., Volkmar, F., Carroll, D., Lancor, A., Tierney, E., Ghuman, J., Gonzalez, N. M., Grados, M., Vitiello, B., Ritz, L., Davies, M., Robinson, J., McMahon, D., & Research Units on Pediatric Psychopharmacology Autism Network. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314–321. https://​doi.​org/​10.​1056/​NEJMoa013171CrossRefPubMed
go back to reference Momtazmanesh, S., Amirimoghaddam-Yazdi, Z., Moghaddam, H. S., Mohammadi, M. R., & Akhondzadeh, S. (2020). Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial. Psychiatry and Clinical Neurosciences, 74, 398–405. https://doi.org/10.1111/pcn.13016CrossRefPubMed Momtazmanesh, S., Amirimoghaddam-Yazdi, Z., Moghaddam, H. S., Mohammadi, M. R., & Akhondzadeh, S. (2020). Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial. Psychiatry and Clinical Neurosciences, 74, 398–405. https://​doi.​org/​10.​1111/​pcn.​13016CrossRefPubMed
go back to reference Myzak, M. C., Tong, P., Dashwood, W. M., Dashwood, R. H., & Ho, E. (2007). Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Experimental Biology & Medicine, 232, 227–234. Myzak, M. C., Tong, P., Dashwood, W. M., Dashwood, R. H., & Ho, E. (2007). Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Experimental Biology & Medicine, 232, 227–234.
go back to reference OSU Rupp. (2005). OSU Autism Rating Scale—DSM-IV (OARS-4). OSU Research Unit on Pediatric Psychopharmacology. OSU Rupp. (2005). OSU Autism Rating Scale—DSM-IV (OARS-4). OSU Research Unit on Pediatric Psychopharmacology.
go back to reference Sedlak, T. W., Nucifora, L. G., Koga, M., Shaffer, L. S., Higgs, C., Tanaka, T., Wang, A. M., Coughlin, J. M., Barker, P. B., Fahey, J. W., & Sawa, A. (2017). Sulforaphane augments glutathione and influences brain metabolites in human subjects: A clinical pilot study. Molecular Neuropsychiatry, 3, 214–222. https://doi.org/10.1159/000487639CrossRef Sedlak, T. W., Nucifora, L. G., Koga, M., Shaffer, L. S., Higgs, C., Tanaka, T., Wang, A. M., Coughlin, J. M., Barker, P. B., Fahey, J. W., & Sawa, A. (2017). Sulforaphane augments glutathione and influences brain metabolites in human subjects: A clinical pilot study. Molecular Neuropsychiatry, 3, 214–222. https://​doi.​org/​10.​1159/​000487639CrossRef
go back to reference Wang, F., Lu, L., Wang, S. B., Zhang, L., Ng, C. H., Ungvari, G. S., Cao, X. L., Lu, J. P., Hou, C. L., Jia, F. J., & Xiang, Y. T. (2018). The prevalence of autism spectrum disorders in China: A comprehensive meta-analysis. Molecular Autism, 14, 717–725. Wang, F., Lu, L., Wang, S. B., Zhang, L., Ng, C. H., Ungvari, G. S., Cao, X. L., Lu, J. P., Hou, C. L., Jia, F. J., & Xiang, Y. T. (2018). The prevalence of autism spectrum disorders in China: A comprehensive meta-analysis. Molecular Autism, 14, 717–725.
go back to reference Wechsler, D. (2003). The Wechsler intelligence scale for children—fourth edition. Pearson. Wechsler, D. (2003). The Wechsler intelligence scale for children—fourth edition. Pearson.
Metagegevens
Titel
Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial
Auteurs
Jianjun Ou
Robert C. Smith
Russell H. Tobe
Jingjing Lin
Jen Arriaza
Jed W. Fahey
Ruiting Liu
Ying Zeng
Yanan Liu
Lian Huang
Yidong Shen
Yamin Li
Daomeng Cheng
Brian Cornblatt
John M. Davis
Jingping Zhao
Renrong Wu
Hua Jin
Publicatiedatum
24-11-2022
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 2/2024
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-022-05784-9

Andere artikelen Uitgave 2/2024

Journal of Autism and Developmental Disorders 2/2024 Naar de uitgave